Back

Resorbable venous closure system for vascular closure after single shot device by pulmonary vein isolation: The VASC-AF pilot study

12 April 2026 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation ablation: procedural workflows Rhythm Control, Catheter Ablation EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Professor Christian-Hendrik Heeger

Asklepios Clinic Altona, Hamburg (Germany)

6 More presentations in this session

Presentation thumbnail
Occupational fetal dose during interventional electrophysiology in pregnancy: a prospective trimester-stratified dosimetry study under ALARA principle and 3D electroanatomical mapping
Doctor V. Buia (Fuerth, DE)
Abstract Slides Video
Presentation thumbnail
Novel mapping-integrated pulsed-field ablation technology for pulmonary vein isolation in patients with atrial fibrillation: learning curve, efficiency, and safety
Doctor G. Mitacchione (Brescia, IT)
Abstract Slides Video
Presentation thumbnail
Comparison of mechanical/optical and microfluidic electrochemical point-of-care ACT systems during transseptal ablation under continuous anticoagulation
Doctor K. Krieger (Frankfurt, DE)
Abstract Slides Video
Presentation thumbnail
Safety, efficacy and reproducibility of a simplified strategy to achieve pulmonary vein isolation using radiofrequency ablation
Doctor J. Diaz (Medellin, CO)
Abstract Slides Video
Presentation thumbnail
Right phrenic nerve localization using cardiac tomography scanning: a correlation study
Doctor A. Cersosimo (Barcelona, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation ablation: procedural workflows

The Event

Event poster

EHRA 2026

12 April - 14 April 2026
You may be interested in
thumbnail
Congress Session
Atrial fibrillation catheter ablation (1)
thumbnail
Congress Presentation
Real-life results of pulmonary vein isolation with the PulseSelect system. Experience of a single tertiary center.
thumbnail
Congress Session
Late-Breaking Science: clinical

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources